Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome Grant

Aerosolized Chemically Modified Tetracycline Nanoformulation for the Treatment of Acute Respiratory Distress Syndrome .

date/time interval

  • April 2, 2024 - November 30, 2024

awarded by

subcontracted through

sponsor award ID

  • Agreement / Prime 1R42HL166050-01A1

contributor